TARGET PharmaSolutions Appoints Neal Bibeau Chief Executive Officer

Ads

You May Also Like

Aptose to Participate in Upcoming Investor Conferences In March 2018

SAN DIEGO and TORONTO, March 06, 2018 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” ...

Mesoblast Receives A$29.6 Million Following Share Issue to Mallinckrodt

NEW YORK and MELBOURNE, Australia, Jan. 09, 2017 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO) ...